Search

Displaying results 4821 - 4830 of 10000 in total
  1. Drug

    Mucor circinelloides f. lusitanicus

    go.drugbank.com/drugs/DB15525
    Approved

    Mucor circinelloides f. lusitanicus allergenic extract is used in allergenic testing.

  2. Drug

    Coffea arabica seed, roasted

    go.drugbank.com/drugs/DB15603
    Approved

    Coffea arabica seed, roasted allergenic extract is used in allergenic testing.

  3. Drug

    Pirlindole

    go.drugbank.com/drugs/DB09244
    Experimental

    It was developed and is currently used as an antidepressant in Russia. Its chemical structure is similar to metralindole, and it also shares pharmacological properties with this drug. … The antidepressant efficacy and safety of pirlindole have been demonstrated in numerous studies and, supported by many years of clinical experience in the treatment of depression.

  4. Drug

    Methyl-D9-choline

    go.drugbank.com/drugs/DB12628
    Investigational

    Methyl-D9-choline is under investigation in clinical trial NCT01807910 (ER Stress in NAFLD).

  5. Drug

    Montmorillonite

    go.drugbank.com/drugs/DB13654
    Investigational

    Categories: Compounds used in a research, industrial, or household settingProducts: SmectaGo 3g Oral Suspension In Sachet
  6. Drug

    Metildigoxin

    go.drugbank.com/drugs/DB13401
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Sodium apolate

    go.drugbank.com/drugs/DB13477
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Betadex

    go.drugbank.com/drugs/DB03995
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Aluminum acetate

    go.drugbank.com/drugs/DB14518
    ApprovedInvestigational

    Products: ACID MANTLE N LOCION, ACID MANTLE® N LOCION.
  10. Drug

    Parsaclisib

    go.drugbank.com/drugs/DB14867
    Investigational

    Parsaclisib is under investigation in clinical trial NCT03126019 (An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)).